Hub gene target of glioblastoma: LOX, SERPINH1 and TGFBI

Glioblastoma (GBM) is a malignant tumor. The long-term prognosis of the patients is poor. Therefore, it is of important clinical value to further explore the pathogenesis and look for molecular markers for early diagnosis and targeted treatment. Two expression profiling datasets [GSE50161 (GPL570 pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shuyuan, Zhang, Weiwei, Wu, Bin, Xia, Liang, Li, Liwen, Jin, Kai, Zou, Yangfan, Sun, Caixing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666166/
https://www.ncbi.nlm.nih.gov/pubmed/36397358
http://dx.doi.org/10.1097/MD.0000000000031418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666166/
https://www.ncbi.nlm.nih.gov/pubmed/36397358
http://dx.doi.org/10.1097/MD.0000000000031418

Ejemplares similares